Brevan Howard Capital Management’s Nuvation Bio NUVB Stock Holding History

Brevan Howard Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$226K	Buy	+52,655	New	+$293K	﹤0.01%	1822
2025 Q4	–	Sell	-203,002	Closed	-$751K	–	2141
2025 Q3	$751K	Sell	203,002 -29,795	-13%	-$81.2K	﹤0.01%	1050
2025 Q2	$454K	Buy	232,797 +176,137	+311%	+$367K	﹤0.01%	1393
2025 Q1	$99.7K	Buy	+56,660	New	+$129K	﹤0.01%	1053
2024 Q4	–	Sell	-53,632	Closed	-$123K	–	1315
2024 Q3	$123K	Buy	+53,632	New	+$164K	﹤0.01%	1056
2024 Q1	–	Sell	-32,723	Closed	-$49.4K	–	1245
2023 Q4	$49.4K	Buy	+32,723	New	+$42.1K	﹤0.01%	995

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brevan Howard Capital Management's NUVB Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Nuvation Bio (NUVB) in Q1 2026: 52,655 shares worth $226K. The stake represents ﹤0.01% of the portfolio and ranks #1822 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in NUVB as recently as Q3 2025.

Brevan Howard Capital Management first reported a position in NUVB in Q4 2023 and has held it in 6 quarters since. The position peaked at $751K in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

Brevan Howard Capital Management held 52,655 shares of Nuvation Bio worth $226K as of Q1 2026.
Nuvation Bio was a new Brevan Howard Capital Management position in Q1 2026.
Nuvation Bio made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1822 holding.
Brevan Howard Capital Management first reported a position in Nuvation Bio in Q4 2023 and has held it in 6 quarters since.
Brevan Howard Capital Management's Nuvation Bio position peaked at $751K in Q3 2025.
231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.